Jane Street’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $562K | Sell |
6,462
-421,183
| -98% | -$25.4M | ﹤0.01% | 7729 |
|
|
2026
Q1 | $17.2M | Buy |
427,645
+218,574
| +105% | +$8.17M | ﹤0.01% | 1920 |
|
|
2025
Q4 | $7.28M | Buy |
209,071
+204,972
| +5,001% | +$16.1M | ﹤0.01% | 2714 |
|
|
2025
Q3 | $341K | Sell |
4,099
-71,716
| -95% | -$5.19M | ﹤0.01% | 8665 |
|
|
2025
Q2 | $5.56M | Buy |
+75,815
| New | +$5.5M | ﹤0.01% | 2855 |
|
|
2025
Q1 | – | Sell |
-133,888
| Closed | -$8.15M | – | 9568 |
|
|
2024
Q4 | $6.75M | Buy |
133,888
+78,262
| +141% | +$4.1M | ﹤0.01% | 2295 |
|
|
2024
Q3 | $2.57M | Sell |
55,626
-88,515
| -61% | -$3.15M | ﹤0.01% | 3984 |
|
|
2024
Q2 | $4.68M | Buy |
144,141
+126,207
| +704% | +$3.46M | ﹤0.01% | 3058 |
|
|
2024
Q1 | $452K | Sell |
17,934
-73,244
| -80% | -$1.73M | ﹤0.01% | 6844 |
|
|
2023
Q4 | $2.96M | Buy |
91,178
+24,102
| +36% | +$662K | ﹤0.01% | 3659 |
|
|
2023
Q3 | $1.83M | Sell |
67,076
-27,441
| -29% | -$794K | ﹤0.01% | 4206 |
|
|
2023
Q2 | $2.1M | Buy |
94,517
+61,413
| +186% | +$1.41M | ﹤0.01% | 4091 |
|
|
2023
Q1 | $717K | Buy |
33,104
+20,409
| +161% | +$447K | ﹤0.01% | 5673 |
|
|
2022
Q4 | $258K | Sell |
12,695
-40,028
| -76% | -$1M | ﹤0.01% | 7275 |
|
|
2022
Q3 | $1.35M | Sell |
52,723
-15,939
| -23% | -$427K | ﹤0.01% | 4890 |
|
|
2022
Q2 | $1.63M | Sell |
68,662
-25,365
| -27% | -$553K | ﹤0.01% | 4542 |
|
|
2022
Q1 | $2.12M | Sell |
94,027
-8,451
| -8% | -$180K | ﹤0.01% | 4652 |
|
|
2021
Q4 | $2.03M | Buy |
+102,478
| New | +$2.08M | ﹤0.01% | 4462 |
|
|
2021
Q3 | – | Sell |
-21,744
| Closed | -$455K | – | 10001 |
|
|
2021
Q2 | $478K | Buy |
+21,744
| New | +$484K | ﹤0.01% | 7330 |
|
|
2020
Q4 | – | Sell |
-112,052
| Closed | -$2.36M | – | 7542 |
|
|
2020
Q3 | $1.95M | Buy |
+112,052
| New | +$1.79M | ﹤0.01% | 3082 |
|
|
2019
Q4 | – | Sell |
-10,207
| Closed | -$144K | – | 5120 |
|
|
2019
Q3 | $144K | Buy |
+10,207
| New | +$125K | ﹤0.01% | 4728 |
|
|
2019
Q2 | – | Sell |
-12,240
| Closed | -$144K | – | 5188 |
|
|
2019
Q1 | $144K | Sell |
12,240
-114,617
| -90% | -$1.42M | ﹤0.01% | 4720 |
|
|
2018
Q4 | $1.7M | Buy |
+126,857
| New | +$1.68M | ﹤0.01% | 1925 |
|
|
2018
Q1 | – | Sell |
-24,960
| Closed | -$451K | – | 4863 |
|
|
2017
Q4 | $451K | Sell |
24,960
-23,134
| -48% | -$419K | ﹤0.01% | 3305 |
|
|
2017
Q3 | $928K | Buy |
+48,094
| New | +$717K | ﹤0.01% | 2375 |
|
|
2017
Q2 | – | Sell |
-13,933
| Closed | -$153K | – | 4386 |
|
|
2017
Q1 | $153K | Buy |
+13,933
| New | +$122K | ﹤0.01% | 3919 |
|
Other funds holding CORT
ISL
PA
Jane Street's CORT Position: Q2 2026 in Review
Jane Street reduced its Corcept Therapeutics (CORT) stake by 98% in Q2 2026, selling an estimated $25.4M and leaving 6,462 shares worth $562K. The position accounts for ﹤0.01% of the portfolio, ranked #7729.
Jane Street first reported a position in CORT in Q1 2017 and has held it in 26 quarters since. The position peaked at $17.2M in Q1 2026. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Jane Street held 6,462 shares of Corcept Therapeutics worth $562K as of Q2 2026.
- Jane Street sold 421,183 Corcept Therapeutics shares in Q2 2026, an estimated $25.4M.
- Corcept Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7729 holding.
- Jane Street first reported a position in Corcept Therapeutics in Q1 2017 and has held it in 26 quarters since.
- Jane Street's Corcept Therapeutics position peaked at $17.2M in Q1 2026.
- 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.